News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics has closed its angel investment round raising
21 January 2014
OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development
5 November 2013
The contract was signed with the National Center for Research and Development
18 December 2009